1985
DOI: 10.1159/000118212
|View full text |Cite
|
Sign up to set email alerts
|

Electroencephalographic and Psychometric Assessment of the CNS Effects of Single Doses of Guanfacine Hydrochloride (Estulic®) and Clonidine (Catapres®)

Abstract: A double-blind, placebo-controlled study was carried out in 10 young healthy volunteers to investigate the effects of single doses of 1 and 2 mg guanfacine hydrochloride (Estulic®) and 0.15 and 0.3 mg clonidine (Catapres®) on the electroencephalogram (EEG), subjective mental and emotional state, blood pressure and heart rate. These doses are considered to be equipotent with regard to their antihypertensive effects, as shown in long-term therapeutic trials. Each subject received all five treatments in random se… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
5
0

Year Published

1993
1993
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(8 citation statements)
references
References 17 publications
3
5
0
Order By: Relevance
“…Behaviorally, GUAN leads to improvement in ADHD symptoms 8,11,12 ; however, neurophysiologically, guanfacine appeared to lower alpha power, which was subsequently associated with slower reaction time, higher reaction time variability, and a trend towards lower performance on tasks measuring inhibition. This result is similar to the only previous study examining EEG correlates of guanfacine among humans 22 . Among 10 healthy adults, guanfacine resulted in alpha power decrease with concomitant participant report of significantly reduced alertness, both of which were interpreted as being consistent with a central nervous system depressant effect.…”
Section: Discussionsupporting
confidence: 90%
“…Behaviorally, GUAN leads to improvement in ADHD symptoms 8,11,12 ; however, neurophysiologically, guanfacine appeared to lower alpha power, which was subsequently associated with slower reaction time, higher reaction time variability, and a trend towards lower performance on tasks measuring inhibition. This result is similar to the only previous study examining EEG correlates of guanfacine among humans 22 . Among 10 healthy adults, guanfacine resulted in alpha power decrease with concomitant participant report of significantly reduced alertness, both of which were interpreted as being consistent with a central nervous system depressant effect.…”
Section: Discussionsupporting
confidence: 90%
“…Martin and Kay [31] also reviewed evidence that morphine induces a slowing o f alpha waves and an increase in theta and delta waves in animals and man, and Oliverio et al [32] reported that BE administration resulted in increased high-voltage low-frequency E E G activity in rats, findings that may be consistent with our observed correlation between prednisone-induced changes in C S F BE and slowing o f brain wave activity. Lastly, Yamadera et al [33] and Fink and Irwin [34] reported that acute doses of the central alpha-2-receptor agonist drugs, clonidine and guanfacine (both o f which lower N E release), increase slow wave activity and de crease alpha activity in man, findings consistent with our observed relationship between decreased C S F levels of N E and decreased alpha activity. Our results, although preliminary and based on a relative ly small sample, suggest that relatively brief courses of exogenous corticosteroid administration are associated with significant brain electrophysiologic changes.…”
Section: Discussionsupporting
confidence: 90%
“…Clonidine, an agonist at presynaptic adrenergic alpha 2 receptors, has a potent influence on alpha activity. In healthy volunteers, clonidine suppresses alpha activity in wake EEG (Yamadera et al, 1985;Bischoff et al, 1998). In accordance with these studies, the blockade of alpha 2 receptors with mirtazapine results in the increase of alpha power.…”
Section: Discussionsupporting
confidence: 71%